Cargando…
In-silico screening to delineate novel antagonists to SARS-CoV-2 nucleocapsid protein
Since its inception, SARS-CoV-2 has crossed all borders and continues rampaging around the globe, causing profound economic damage and heavy burden on the scientific community and the healthcare fraternity and facilities. With the emergence of new variants, the global pandemic has prolonged and rais...
Autores principales: | Shahanshah, Mohd Fardeen Husain, Anvitha, D., Gupta, Vandana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212792/ https://www.ncbi.nlm.nih.gov/pubmed/35757560 http://dx.doi.org/10.1016/j.pce.2022.103188 |
Ejemplares similares
-
SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study
por: Khan, Muhammad Tahir, et al.
Publicado: (2020) -
In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Nucleocapsid Through Molecular Docking-Based Drug Repurposing
por: Afreen, Rukhsar, et al.
Publicado: (2022) -
Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
por: Guo, Wenhan, et al.
Publicado: (2021) -
Immunized mice naturally process in silico-derived peptides from the nucleocapsid of SARS-CoV-2
por: Campos-Ruíz, Mario Aldair, et al.
Publicado: (2023) -
The Epitope Study on the SARS-CoV Nucleocapsid Protein
por: Li, Shuting, et al.
Publicado: (2003)